Period Ending | Apr 3, 2009 | Mar 28, 2008 | Mar 31, 2007 |
Total Revenue
|
6,149,854
|
5,874,419
|
5,199,366
| Cost of Revenue | 1,226,927 | 1,220,330 | 1,215,826 | |
Gross Profit
|
4,922,927
|
4,654,089
|
3,983,540
| |
|
Operating Expenses |
|
Research Development | 879,702 | 895,242 | 866,882 |
|
Selling General and Administrative | 2,728,792 | 2,762,906 | 2,325,178 |
|
Non Recurring | 7,550,882 | 168,530 | 70,236 |
|
Others | 233,461 | 225,131 | 201,502 |
|
|
|
Total Operating Expenses | 11,392,837 | 4,051,809 | 3,463,798 | | |
Operating Income or Loss
|
(6,469,910)
|
602,280
|
519,742
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 45,437 | 139,723 | 139,113 |
|
Earnings Before Interest And Taxes | (6,424,473) | 742,003 | 658,855 |
|
Interest Expense | 29,705 | 29,480 | 27,233 |
|
Income Before Tax | (6,454,178) | 712,523 | 631,622 |
|
Income Tax Expense | 221,630 | 248,673 | 227,242 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (6,728,870) | 463,850 | 404,380 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
(6,728,870)
|
463,850
|
404,380
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
($6,728,870)
|
$463,850
|
$404,380
|
|